Anti-cancer effects of a novel compound HS-113 on cell growth, apoptosis, and angiogenesis in human hepatocellular carcinoma cells

Cancer Letters

Volumn 306, Issue 2, 2011, Pages 190-196

  Choi, Myung Joo ^a   Jung, Kyung Hee ^a   Kim, Donghee ^b   Lee, Hyunseung ^a   Zheng, Hong Mei ^a   Park, Byung Hee ^a   Hong, Sang Won ^a   Kim, Mi Hyun ^c   Hong, Sungwoo ^b   Hong, Soon Sun ^a  

^a Inha University School of Medicine   (South Korea)

^b Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^c YANBIAN UNIVERSITY   (China)

Author keywords

Angiogenesis; Apoptosis; HCC; HS 113

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; BENZOFURAN DERIVATIVE; CASPASE 3; CYCLIN D1; HS 113; HYPOXIA INDUCIBLE FACTOR 1ALPHA; N [5 (2 BROMOBENZYL)THIAZOLE YL]BENZOFURAN 2 CARBOXAMIDE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); PROTEIN P27; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL GROWTH; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG STRUCTURE; GROWTH INHIBITION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; NICK END LABELING; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN SECRETION; UMBILICAL VEIN ENDOTHELIAL CELL;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BENZOFURANS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL CYCLE PROTEINS; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LIVER NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-BCL-2; THIAZOLES; UMBILICAL VEINS;

EID: 79955479914     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.03.005     Document Type: Article

References (25)

1. Lee J.S., Chu I.S., Heo J., Calvisi D.F., Sun Z., Roskams T., Durnez A., Demetris A.J., Thorgeirsson S.S. Hepatology 2004, 40:667-676.
2. Schwartz M., Roayaie S., Konstadoulakis M. Nat. Clin. Pract. Oncol. 2007, 4:424-432.
3. Fiorentino M., Altimari A., Ravaioli M., Gruppioni E., Gabusi E., Corti B., Vivarelli M., Bringuier P.P., Scoazec J.Y., Grigioni W.F., D'Errico-Grigioni A. Clin. Cancer Res. 2004, 10:1789-1795.
4. Abdel-Wahab B.F., Abdel-Aziz H.A., Ahmed E.M. Arch. Pharm. (Weinheim) 2008, 341:734-739.
5. N. Siddiqui, Shaquiquzzaman, M. Ur Rahman, M.F. Arshad, W. Ahsan, M.S. Alam, S. Ahmed, Acta Pol. Pharm. 67 (2010) 239-246.
6. Wang S., Midgley C.A., Scaerou F., Grabarek J.B., Griffiths G., Jackson W., Kontopidis G., McClue S.J., McInnes C., Meades C., Mezna M., Plater A., Stuart I., Thomas M.P., Wood G., Clarke R.G., Blake D.G., Zheleva D.I., Lane D.P., Jackson R.C., Glover D.M., Fischer P.M. J. Med. Chem. 2010, 53:4367-4378.
7. Poon R.T., Ng I.O., Lau C., Yu W.C., Yang Z.F., Fan S.T., Wong J. J. Clin. Oncol. 2002, 20:1775-1785.
8. Poon R.T., Ng I.O., Lau C., Zhu L.X., Yu W.C., Lo C.M., Fan S.T., Wong J. Ann. Surg. 2001, 233:227-235.
9. Weng J.R., Tsai C.H., Kulp S.K., Chen C.S. Cancer Lett. 2008, 262:153-163.
10. Sim H.M., Lee C.Y., Ee P.L., Go M.L. Eur. J. Pharm. Sci. 2008, 35:293-306.
11. Kuramoto M., Sakata Y., Terai K., Kawasaki I., Kunitomo J., Ohishi T., Yokomizo T., Takeda S., Tanaka S., Ohishi Y. Org. Biomol. Chem. 2008, 6:2772-2781.
12. Tsao A.S., Kim E.S., Hong W.K. CA Cancer J. Clin. 2004, 54:150-180.
13. Greenwald P. BMJ 2002, 324:714-718.
14. Hashimoto T., He Z., Ma W.Y., Schmid P.C., Bode A.M., Yang C.S., Dong Z. Cancer Res. 2004, 64:3344-3349.
15. Shan Y., Sun C., Zhao X., Wu K., Cassidy A., Bao Y. Int. J. Oncol. 2006, 29:883-888.
16. Toyoshima H., Hunter T. Cell 1994, 78:67-74.
17. Ziegler D.S., Kung A.L. Curr. Opin. Oncol. 2008, 20:97-103.
18. Reed J.C. Am. J. Pathol. 2000, 157:1415-1430.
19. Sun S.Y., Hail N., Lotan R. J. Natl. Cancer Inst. 2004, 96:662-672.
20. Ashe P.C., Berry M.D. Prog. Neuropsychopharmacol. Biol. Psychiatr. 2003, 27:199-214.
21. Izban K.F., Wrone-Smith T., Hsi E.D., Schnitzer B., Quevedo M.E., Alkan S. Am. J. Pathol. 1999, 154:1439-1447.
22. Li L., Ahmed B., Mehta K., Kurzrock R. Mol. Cancer Ther. 2007, 6:1276-1282.
23. Mirzoeva S., Kim N.D., Chiu K., Franzen C.A., Bergan R.C., Pelling J.C. Mol. Carcinog. 2008, 47:686-700.
24. Schoppmann S.F., Fenzl A., Schindl M., Bachleitner-Hofmann T., Nagy K., Gnant M., Horvat R., Jakesz R., Birner P. Breast Cancer Res. Treat. 2006, 99:135-141.
25. Jung J.E., Lee H.G., Cho I.H., Chung D.H., Yoon S.H., Yang Y.M., Lee J.W., Choi S., Park J.W., Ye S.K., Chung M.H. FASEB J. 2005, 19:1296-1298.